Great news, bit of a sideshow as we're all waiting on an update from drilling in Greece, but good to have more positive news to prop us up in the meantime.
I hadn't realised HG-CT-1 could be commercialised on the back of positive phase 1 data.
Now I'm wondering if data from Estonia could be used instead of a Phase 2 trial? It's not going to provide the same data as a double blind study, but is that always necessary?